Tool, Stripper W/BLD, 14S, Autoclavable; The Fiber Stripper is a tool provided for stripping t...

FDA Device Recall #Z-2177-2015 — Class II — May 28, 2015

Recall Summary

Recall Number Z-2177-2015
Classification Class II — Moderate risk
Date Initiated May 28, 2015
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm American Medical Systems Innovation Center - Silicon Valley
Location San Jose, CA
Product Type Devices
Quantity 16,710 total affected devices

Product Description

Tool, Stripper W/BLD, 14S, Autoclavable; The Fiber Stripper is a tool provided for stripping the protective jacket off the end of an Endostat or SureFlex Fiber. The Fiber Stripper does not come in to direct contact with the patient. It is available in several sizes, corresponding to the Endostat or SureFlex Fiber core diameter size.

Reason for Recall

validation data related to cleaning instructions and sterilization methods and the methods defined in instructions for use (IFU) for the Sureflex Reusable Fibers and the Reusable Stripper and Cleaver Accessories do not meet the new guidance on qualifying reusable products

Distribution Pattern

Worldwide Distribution - US Nationwide in the countries of: Argentina France Morocco, South Africa, Australia, Germany, Netherlands, Spain, Austria, Greece, New Zealand, Sri Lanka, Belgium, Guatemala, Norway, Switzerland, Bolivia, India, Panama, Thailand, Brazil, Ireland, Peru, Turkey, Canada, Israel, Poland, United Kingdom, Chile, Italy, Portugal, United States, Colombia, Korea, Qatar, Uruguay, Costa Rica, Lebanon, Romania, Finland, Malaysia and Saudi Arabia.

Lot / Code Information

Model 80-10003-002; All product manufactured from April 8, 2012 to April 8, 2015

Other Recalls from American Medical Systems Innovation C...

Recall # Classification Product Date
Z-2178-2015 Class II Tool, Stripper W/BLD, 18S, Nonautoclavable; ... May 28, 2015
Z-2170-2015 Class II Fiber Cleaver; Fiber Cleaver is also used to ... May 28, 2015
Z-2181-2015 Class II Tool, Stripper W/BLD, 44S, Autoclavable; The... May 28, 2015
Z-2185-2015 Class II Stripper, 0.4mm Disposable EndoStat Fiber, ... May 28, 2015
Z-2164-2015 Class II Fiber Stripper, 150¿m, Autoclavable; The Fib... May 28, 2015

Frequently Asked Questions

Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.